Lhasa Limited shared knowledge shared progress

Lhasa Limited releases new data to its AI/PDE project users

Date: 26 April 2021

Time: 15:00

AIPDE news piece image

Since 2017, the AI/PDE project has brought together top pharmaceutical organisations to share and harmonise Acceptable Intake (AI) and Permitted Daily Exposure (PDE) data.

Using Lhasa’s Vitic platform, Vitic AI/PDE is one of several projects initiated by Lhasa Limited that enables pre-competitive data sharing. 

With newly added data records and substances, the 2021.1 AI/PDE database contains the following:

  • New data records = 3
  • Total data records = 252
  • New substances = 1
  • Total substances = 165

AI and PDE assessments take time to put together and rarely make use of proprietary data. The sharing of data in this context can save an organisation significant time, effort and money without disclosing sensitive information.There are a number of benefits that can be achieved by joining the data sharing consortium.

See the AI/PDE project page or to enquire about joining the consortium, please get in touch.

  • Summary:

    Lhasa Limited is pleased to release new data to its AI/PDE project users.

  • Categories:
    • Collaborative Projects
    • Vitic
    • Releases

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.